Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Select Therapeutics submits pre-IND in Canada for anticancer compound

April 9, 1999

Aronex initiates phase I/II trial of Atragen in bladder cancer

April 9, 1999

EntreMed and NCI sign CRADA for 2-methoxyestradiol

April 8, 1999

Enzon files IND for PEG-camptothecin

April 8, 1999

Growth factor receptor PTK inhibitors in development by American Cyanamid

April 7, 1999

Schering-Plough seeks further E.U. approval for Temodal

April 7, 1999

FDA approves DepoCyt for treatment of lymphomatous meningitis

April 6, 1999

Celgene and NCI collaborate on thalidomide cancer trial

April 6, 1999

Noncardiotoxic anthracyclines disclosed by Gem

April 6, 1999

Phase II trials of first anticancer dioxolane nucleoside analogue begin

April 5, 1999

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...